ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow
Go back to ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow| Carl Zeiss Meditec AG Unsponsored ADR (AMEX: CZMWY) | Delayed: 37.33 -0.63 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.96 | 52 Week High | $41.68 | |||
| Open | $38.16 | 52 Week Low | $28.06 | |||
| Day High | $38.16 | P/E | N/A | |||
| Day Low | $37.33 | EPS | $0.00 | |||
| Volume | 3,335 | |||||
